← Product Code [FMF](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF) · K143757 # ANUTRA Feedback Aspiration Syringe (K143757) _Anutra Medical, Inc. · FMF · Jan 8, 2015 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K143757 ## Device Facts - **Applicant:** Anutra Medical, Inc. - **Product Code:** [FMF](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF.md) - **Decision Date:** Jan 8, 2015 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5860 - **Device Class:** Class 2 - **Review Panel:** General Hospital - **Attributes:** 3rd-Party Reviewed ## Indications for Use The ANUTRA Feedback Aspiration Syringe is intended for use by healthcare professionals for general purpose fluid aspiration/injection. ## Device Story The ANUTRA Feedback Aspiration Syringe is a 5mL piston-style control syringe used by healthcare professionals for fluid aspiration and injection. It consists of a polypropylene barrel, plunger rod, and synthetic polyisoprene rubber plunger. The device features a finger ring on the plunger rod and tab interfaces with the barrel to provide audible and tactile feedback during operation, allowing for one-handed use. The internal barrel surface is lubricated with polydimethylsiloxane. The device is single-use, non-pyrogenic, and sterilized via gamma irradiation. It connects to other devices via a 6% male Luer Lock. The device is used in clinical settings to facilitate controlled fluid delivery or aspiration, with the tactile/audible feedback mechanism assisting the clinician in monitoring the plunger position during the procedure. ## Clinical Evidence Bench testing only. No clinical data. Testing included ISO 7886-1 (cleanliness, lubricant, capacity, leakage, forces), ISO 594-2 (Luer fitting performance), sterile barrier packaging integrity (ASTM F2096, F88, F1886), and biocompatibility (cytotoxicity, irritation, sensitization, systemic toxicity, hemocompatibility). ## Technological Characteristics Piston syringe; 5mL nominal volume; polypropylene copolymer barrel/plunger rod; polyisoprene rubber plunger; polydimethylsiloxane lubricant. Features 6% male Luer Lock. Sterilized by gamma irradiation. Meets ISO 7886-1 and ISO 594-2 standards. Mechanical feedback mechanism via plunger rod tabs. ## Regulatory Identification A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body. ## Predicate Devices - BD Single Use, Hypodermic Syringe ([K110771](/device/K110771.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around an emblem. The emblem depicts a stylized human figure with three faces in profile, representing the department's focus on health and well-being. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 8,2015 Anutra Medical Inc. c/o Cameron Perkins 1000 Perimeter Pike, Suite E Morrisville, NC 27560 Re: K143757 Trade/Device Name: Anutra Feedback Aspiration Syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Product Code: FMF Regulatory Class: II Dated: December 18, 2014 Received: December 31, 2014 Dear Cameron Perkins: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {1}------------------------------------------------ forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Susan Runno DDS, MA Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ | DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use | Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017
See PRA Statement below. | |------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------| | 510(k) Number (if known)
K143757 | | | Device Name | | ANUTRA Feedback Aspiration Syringe ### Indications for Use (Describe) The ANUTRA Feedback Aspiration Syringe is intended for use by healtheare professionals for general purpose fluid aspiration/injection. Type of Use (Select one or both, as applicable) 2 Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED. FOR FDA USE ONLY Concurrence of Center for Devices and Radiological Health (CDRH) (Signature) ### This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." FORM FDA 3881 (1/14) Page 1 of 1 PSC Publishing Services (301) 443-6740 EFF {3}------------------------------------------------ ### 5.0 510(k) Summary #### 5.1. Submitter Information | Company Name: | Anutra Medical, Inc. | |---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Company Address: | 1000 Perimeter Pk, Suite E Morrisville, NC 27560 USA | | Company Phone: | 844-268-8721 | | Company Fax: | 844-268-8721 | | Contact Person: | Cameron Perkins
Anutra Medical, Inc.
Phone: 844-268-8721
Fax: 844-268-8721
Email: cameron@anutramedical.com | | Prepared By: | Kristin Benokraitis
Director of Quality and Operations
Gilero, LLC
4022 Stirrup Creek Drive Suite 300
Durham, NC 27703
Phone: 919-595-8223
Fax: 919-595-8221
Email: kristinb@gilero.com | | Date Summary
Prepared: | December 18, 2014 | ### Device Identification 5.2. | Trade/Proprietary Name: | ANUTRA Feedback Aspiration Syringe | |--------------------------|--------------------------------------------| | Common Name: | Control Syringe | | Classification Name: | Piston Syringe
21CFR 880.5860, Class II | | Classification Panel | General Hospital | | Product Code: | FMF (Syringe, piston) | {4}------------------------------------------------ #### 5.3. Predicate Device The ANUTRA Feedback Aspiration Syringe is substantially equivalent to the following predicate device: | Device | Manufacturer | 510(k) | Date Cleared | |--------------------------------------|----------------------------------|---------|--------------| | BD Single Use,
Hypodermic Syringe | Becton, Dickinson and
Company | K110771 | May 13, 2011 | #### 5.4. Device Description The ANUTRA Feedback Aspiration Syringe is a piston syringe (control syringe) consisting of a plastic barrel which contains a printed graduated scale (5mL nominal volume) and 6% male Luer Lock connection, a plunger, and a plastic plunger rod. The internal surface of the ANUTRA Feedback Aspiration Syringe barrel is lubricated with polydimethylsiloxane (silicone). The plunger rod design contains a finger ring to allow for ease of use, and tab features with interface with the barrel to provide audible and tactile feedback to the user. The ANUTRA Feedback Aspiration Syringe is single-use only, non-pyrogenic, and sterilized by gamma irradiation. #### ર.ડ. Intended Use The ANUTRA Feedback Aspiration Syringe is intended for use by healthcare professionals for general purpose fluid aspiration/injection. #### 5.6. Predicate Device Comparison - Technical Characteristics Equivalency of technical characteristics is demonstrated through a direct comparison of the ANUTRA Feedback Aspiration Syringe and the predicate device listed in the table below. | Technical
Characteristic | Subject Device:
ANUTRA Feedback
Aspiration Syringe | Predicate Device:
BD Single Use, Hypodermic
Syringe (K110771) | |-----------------------------|----------------------------------------------------------|---------------------------------------------------------------------| | Barrel | Yes | Yes | | Plunger Rod | Yes | Yes | | Plunger | Yes | Yes | | Luer Configuration | Luer Lock | 1mL – Luer Slip
3mL and 5mL – Luer Lock | | Nominal Fluid
Volume | 5mL | 1mL, 3mL and 5mL | | Lubrication | Polydimethylsiloxane
(silicone) | Unknown, device assumed to
be lubricated | | Sterilization Method | Gamma irradiation | Ethylene oxide or gamma
irradiation | {5}------------------------------------------------ The predicate device is a piston syringe. The ANUTRA Feedback Aspiration Syringe is a type of piston syringe (specifically, a control syringe). The intended use for the ANUTRA Feedback Aspiration Syringe is the same as its predicate device, the BD Single Use, Hypodermic Syringe (K110771). ## Barrel The volume of fluid contained within the both the ANUTRA Feedback Aspiration Syringe and the predicate device is indicated by graduation marks printed on the outside of the barrel. The ANUTRA Feedback Aspiration Syringe has a plastic barrel with a 5mL nominal fluid volume. A 5mL variant of the predicate device contains the same nominal volume. # Luer Configuration Both the subject device and the predicate device are offered in a male Luer Lock configuration. The predicate device is also available in a Slip Luer configuration (1mL only). ## Nominal Fluid Volume The nominal fluid volume for both the subject device and the predicate device is 5mL. The predicate device is also available in other fluid volumes. ## Lubrication The internal surface of the ANUTRA Feedback Aspiration Syringe is coated with a polydimethylsiloxane (silicone). The predicate device 510(k) summary does not specify whether or not the predicate device is lubricated, however based on an inspection of the predicate device, it is believed to be lubricated. # Plunger Rod & Plunger Both the subject device and the predicate device have a plastic plunger rod and a synthetic rubber plunger; the plunger is attached to the plunger rod with snap-fit retention features. The ANUTRA Feedback Aspiration Syringe plunger rod contains features which provide audible and tactile feedback when the plunger is advanced or retracted, and a finger ring for ease of use and handling the device. The predicate device has a flat push-button on the end of its plunger rod. The mechanism for delivery of fluid is the same for both the subject device and predicate devices. ### Sterilization Method The ANUTRA Feedback Aspiration Syringe is sterilized using gamma irradiation. The predicate device can be sterilized by either gamma irradiation or ethylene oxide. {6}------------------------------------------------ ## Materials The ANUTRA Feedback Aspiration Syringe is constructed of the following polymeric components: - . Barrel: Polypropylene copolymer - Plunger Rod: Polypropylene copolymer ● - Plunger: Synthetic (polyisoprene) rubber ● - Lubrication: Polydimethylsiloxane (silicone) ● The subject device has been tested and meets the biological requirements outlined in ISO 10993-1. A summary of these test results is provided in Section 15 -Biocompatibility. #### 5.7. Predicate Device Comparison - Performance Characteristics The performance data supplied with this submission demonstrates that the ANUTRA Feedback Aspiration Syringe meets the specified requirements and is substantially equivalent to the predicate device. The predicate device (BD Single Use, Hypodermic Syringe) provided an overview of testing completed in the 510(k) Summary (K110771). These tests were used to compare the subject device and the predicate device performance. Tests Performed on Subject Device and Predicate Device (as indicated in the predicate device 510(k) Summary): - · ISO 7886-1 - Section 6 (Limits for Acidity or Alkalinity) o - Section 7 (Limits for Extractable Metals) o - Annex D Liquid leakage at syringe piston under compression O - Annex G Forces to operate the plunger о Tests Performed on Subject Device: - ISO 7886-1 . - o Section 5 (Cleanliness) - Section 8 (Lubricant) o - Section 9 (Tolerance on graduated capacity) O - Section 10 (Graduated Scale) O - Section 11 (Barrel) O - Section 12 (Piston/plunger assembly); Annex B O - Section 13 (Nozzle) O - Section 14.1 (Dead Space) O - Section 14.2 (Freedom from air and liquid leakage past piston); O Annex B and Annex D - Section 15 (Packaging) о - Section 16 (Labeling) O {7}------------------------------------------------ - ISO 594-2 - o Section 3 (Dimensions and tolerances) - Section 4.1 (Gauging) O - Section 5.2 (Liquid leakage from fitting assembly under pressure) O - Section 5.3 (Air leakage into fitting assembly during aspiration) O - Section 5.4 (Separation force of fitting assembly) O - Section 5.5 (Unscrewing torque of fitting assembly) O - Section 5.6 (Ease of assembly) O - Section 5.7 (Resistance to overriding) O - Section 5.8 (Stress cracking) o - Sterile Barrier Packaging Testing ● - o ASTM F2096 11 Standard Test Method for Detecting Gross Leaks in Packaging by Internal Pressurization (Bubble Test) - O ASTM F88-09 Standard Test Method for Seal Strength of Flexible Barrier Materials - o ASTM F1886 / F1886M 09(2013) Standard Test Method for Determining Integrity of Seals for Flexible Packaging by Visual Inspection - . General performance - Syringe package shall be easy to open with gloved hands o - Syringe shall be able to aspirate and deliver using one hand O - Tactile feedback O - o Finger reach - Biocompatibility Testing (ISO 10993) ● - Cytotoxicity by Elution Test (Cytotoxicity) O - Intracutaneous Reactivity (Irritation or Intracutaneous Reactivity) о - Maximization Test for Delayed Hypersensivity (Sensitization) O - Acute Systemic Toxicity (Systemic Toxicity (Acute)) O - Evaluation of Hemocompatibility: Interaction with Blood O (Hemocompatibility/Hemolysis) #### 5.8. Conclusion Test results demonstrated that the ANUTRA Feedback Aspiration Syringe is as safe, as effective and performs as well as or better than the legally marketed predicate device (BD Single Use, Hypodermic Syringe). Based on comparisons of the device's intended use, technology and performance characteristics, the ANUTRA Feedback Aspiration Syringe is substantially equivalent to the indicated predicate device. Any differences between the ANUTRA Feedback Aspiration Syringe and the predicate device have no significant influence on safety or effectiveness. --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K143757](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K143757) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com